| Hnf4a |
Mus musculus |
|
Hnf4a is differentially expressed in 91 experiments [108 up/109 dn]: 52 organism parts: liver [17 up/0 dn], kidney [7 up/1 dn], ...; 3 disease states: normal [1 up/1 dn], lung adenocarcinoma [1 up/0 dn], ...; 24 cell types, 13 compound treatments, 18 developmental stages and 11 other conditions. |
| Hnf-4, Hnf4, Hnf4a, Tcf14, Nr2a1 |
|
nhr-35 (Caenorhabditis elegans)
nhr-31 (Caenorhabditis elegans)
nhr-64 (Caenorhabditis elegans)
HNF4A (Homo sapiens)
HNF4A_RAT (Rattus norvegicus)
nhr-3 (Caenorhabditis elegans)
nhr-88 (Caenorhabditis elegans)
nhr-69 (Caenorhabditis elegans)
nhr-49 (Caenorhabditis elegans)
nhr-97 (Caenorhabditis elegans)
Hnf4 (Drosophila melanogaster)
hnf4a (Danio rerio)
(Compare orthologs)
|
|
|
| Nuclear hormone receptor, ligand-binding, Nuclear hormone receptor, ligand-binding, core, Retinoid X receptor, Zinc finger, nuclear hormone receptor-type, Steroid hormone receptor |
|
|
| RNA polymerase II transcription factor activity, enhancer binding, glucose homeostasis, positive regulation of gene-specific transcription from RNA polymerase II promoter, regulation of gastrulation, response to glucose stimulus |
|
|
|
P49698
|
|
|
|
ENSMUSG00000017950
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Liver
|
Organism part |
|
|
Wild_type
|
Genotype |
|
|
Kidney
|
Organism part |
|
|
Embryonic stem cell
|
Cell type |
|
|
Embryo
|
Developmental stage |
|
|
Spleen
|
Organism part |
|
|
Hypothalamus
|
Organism part |
|
|
Testis
|
Organism part |
|
|
Adult
|
Developmental stage |
|
|
Hematopoietic stem cell
|
Cell type |
|
|
Hippocampus
|
Organism part |
|
|
C57BL/6J
|
Strain or line |
|
|
None
|
Compound treatment |
|
|
Ovary
|
Organism part |
|
|
Lung
|
Organism part |
|
|
Adipose tissue
|
Organism part |
|
|
Colon
|
Organism part |
|
|
Pancreas
|
Organism part |
|
|
E15.5
|
Developmental stage |
|
|
Normal
|
Disease state |
|
|
Somatic cell
|
Cell type |
|
|
Uninfected
|
Infection |
|
|
Control
|
Compound treatment |
|
|
Amygdala
|
Organism part |
|
|
Large intestine
|
Organism part |
|
|
CBA/CaJ
|
Strain or line |
|
|
Small intestine
|
Organism part |
|
|
Skeletal muscle
|
Organism part |
|
|
Quadriceps skeletal muscle
|
Organism part |
|
|
Medial gastrocnemius
|
Organism part |
|
|
Quadriceps muscle
|
Organism part |
|
|
Partial hepatectomy
|
Injury |
|
|
Anterior tibialis
|
Organism part |
|
|
Ileum
|
Organism part |
|
|
Snout epidermis
|
Organism part |
|
|
Spermatid
|
Cell type |
|
|
Jejunum
|
Organism part |
|
|
Allergen
|
Compound treatment |
|
|
Control - PBS
|
Compound treatment |
|
|
Bmal1-/-
|
Genotype |
|
|
E12.5
|
Developmental stage |
|
|
Submandibular gland
|
Organism part |
|
|
Neural
|
Observation |
|
|
Non-neural
|
Observation |
|
|
Spermatogonium
|
Cell type |
|
|
SCA1 knock-in
|
Genotype |
|
|
Neural stem/progenitor cell
|
Cell type |
|
|
SCA1 wild_type
|
Genotype |
|
|
Corpus
|
Organism part |
|
|
Myeloid progenitor cell
|
Cell type |
|
|
E12
|
Developmental stage |
|
|
E8.5
|
Developmental stage |
|
|
Constant darkness
|
Light |
|
|
12 h light:12 h dark
|
Light |
|
|
52.2 kcal per wk for 8 wk
|
Growth condition |
|
|
Lung adenocarcinoma
|
Disease state |
|
|
GABAergic interneuron
|
Cell type |
|
|
8-cell
|
Developmental stage |
|
|
T regulatory cells anti-ICOS-t...
|
Cell type |
|
|
Bone marrow
|
Organism part |
|
|
Stomach
|
Organism part |
|
|
CREM(-/-)
|
Genotype |
|
|
Preoptic
|
Organism part |
|
|
Thymus
|
Organism part |
|
|
TICAM1(-/-)
|
Genotype |
|
|
E13.5
|
Developmental stage |
|
|
Dibenzazepine
|
Compound treatment |
|
|
SCA7 wild_type
|
Genotype |
|
|
SCA7 knock-in
|
Genotype |
|
|
Trachea
|
Organism part |
|
|
Pancreatic islet
|
Organism part |
|
|
Primary osteoblast
|
Cell type |
|
|
Cycloheximide (pretreatment)+ ...
|
Compound treatment |
|
|
GABAergic neuron
|
Cell type |
|
|
Sertoli cell
|
Cell type |
|
|
T8 spindal segment
|
Organism part |
|
|
Trypanosoma congolense
|
Infection |
|
|
Vagina
|
Organism part |
|
|
Cerebellum
|
Organism part |
|
|
Sham surgery
|
Injury |
|
|
Castration
|
Injury |
|
|
Main olfactory epithelium
|
Organism part |
|
|
Site of trauma
|
Observation |
|
|
Bone
|
Organism part |
|
|
Control
|
Infection |
|
|
Mycobacterium tuberculosis
|
Infection |
|
|
Oviduct
|
Organism part |
|
|
Granulocyte-macrophage progeni...
|
Cell type |
|
|
Synovial sarcoma
|
Disease state |
|
|
Digits
|
Organism part |
|
|
Chlorophenylthio-cAMP + glucos...
|
Compound treatment |
|
|
Uterus
|
Organism part |
|
|
Thyroid
|
Organism part |
|
|
Glutamatergic neuron
|
Cell type |
|
|
Pachytene spermatocyte
|
Cell type |
|
|
Cardiomyocyte
|
Cell type |
|
|
E16.5
|
Developmental stage |
|
|
2-cell
|
Developmental stage |
|
|
Adrenal gland
|
Organism part |
|
|
CpG
|
Compound treatment |
|
|
Blastocyst
|
Developmental stage |
|
|
Cingulate cortex homogenate
|
Organism part |
|
|
Late (42 weeks)
|
Disease staging |
|
|
Primordial germ cell
|
Cell type |
|
|
Epidermis
|
Organism part |
|
|
Th1
|
Cell type |
|
|
Th2
|
Cell type |
|
|
AKT transgenic
|
Genotype |
|
|
Interferon-gamma
|
Compound treatment |
|
|
Epiblast
|
Cell type |
|
|
Yersinia enterocolitica WA(pTT...
|
Infection |
|
|
77 kcal for 2 wk, 52.2 kcal fo...
|
Growth condition |
|
|
Cpr-lox control
|
Genotype |
|
|
P16
|
Developmental stage |
|
|
E18
|
Developmental stage |
|
|
Cardiotoxin
|
Compound treatment |
|
|
Litter 2
|
Generation |
|
|
Litter 1
|
Generation |
|
|
P48-Cre;KrasG12D;Ela-Tgfa
|
Genotype |
|
|
DBA/2J
|
Strain or line |
|
|
Pituitary gland
|
Organism part |
|
|
Virgin
|
Developmental stage |
|
|
Parous
|
Developmental stage |
|
|
Heart
|
Organism part |
|
|
Vomeral nasal organ
|
Organism part |
|
|
Feed control
|
Compound treatment |
|
|
Chimpanzee diet
|
Growth condition |
|
|
P23
|
Developmental stage |
|
|
PGC-1 beta transgenic
|
Genotype |
|
|
Female
|
Sex |
|
|
Male
|
Sex |
|
|
Cytarabine sensitive
|
Phenotype |
|
|
Cytarabine resistant
|
Phenotype |
|
|
Ara-C
|
Compound treatment |
|
|
Umbilical cord
|
Organism part |
|
|
PGC-1alpha null
|
Genotype |
|
|
Primary dermal fibroblast
|
Cell type |
|
|
Cortex
|
Organism part |
|
|
Rb-/-
|
Genotype |
|
|
E10.5
|
Developmental stage |
|
|
Cerebral cortex
|
Organism part |
|
|
Oocyte
|
Organism part |
|
|
Epiblast stem cell (EpiSC)
|
Cell type |
|
|
CD45+
|
Cell type |
|
|
CD45-
|
Cell type |
|
|
Pituitary
|
Organism part |
|
|
LSK, Flk2- Ncad-
|
Phenotype |
|
|
R848
|
Compound treatment |
|
|
1-cell
|
Developmental stage |
|
|
Genital ridge/mesonephros
|
Organism part |
|
|
Whole heart
|
Organism part |
|
|
Tcf1-/-
|
Genotype |
|
|
SCD1 -/-
|
Genotype |
|
|
Hnf4a null
|
Genotype |
|
|
|
|
|
Processing time: 0.174 secs.